Related references
Note: Only part of the references are listed.A Randomized, Controlled Trial of Raltegravir Intensification in Antiretroviral-treated, HIV-infected Patients with a Suboptimal CD4+ T Cell Response
Hiroyu Hatano et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Randomized control trials using a tablet formulation of hyperimmune bovine colostrum to prevent diarrhea caused by enterotoxigenic Escherichia coli in volunteers
Wlodzimierz Otto et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2011)
Short-Course Raltegravir Intensification Does Not Reduce Persistent Low-Level Viremia in Patients with HIV-1 Suppression during Receipt of Combination Antiretroviral Therapy
D. McMahon et al.
CLINICAL INFECTIOUS DISEASES (2010)
Persistent Microbial Translocation and Immune Activation in HIV-1-Infected South Africans Receiving Combination Antiretroviral Therapy
Edana Cassol et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Biological Determinants of Immune Reconstitution in HIV-Infected Patients Receiving Antiretroviral Therapy: The Role of Interleukin 7 and Interleukin 7 Receptor α and Microbial Translocation
Reena Rajasuriar et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
HIV-1 replication and immune dynamics are affected by raltegravir intensification of HAART-suppressed subjects
Maria J. Buzon et al.
NATURE MEDICINE (2010)
Prevention and Treatment of Influenza with Hyperimmune Bovine Colostrum Antibody
Wy Ching Ng et al.
PLOS ONE (2010)
The Effect of Raltegravir Intensification on Low-level Residual Viremia in HIV-Infected Patients on Antiretroviral Therapy: A Randomized Controlled Trial
Rajesh T. Gandhi et al.
PLOS MEDICINE (2010)
Impact of adding maraviroc to antiretroviral regimens in patients with full viral suppression but impaired CD4 recovery
Olena Stepanyuk et al.
AIDS (2009)
Plasma Levels of Bacterial DNA Correlate with Immune Activation and the Magnitude of Immune Restoration in Persons with Antiretroviral-Treated HIV Infection
Wei Jiang et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: a multicentre, double-blind randomised controlled trial
Jeffrey L. Lennox et al.
LANCET (2009)
Treatment intensification does not reduce residual HIV-1 viremia in patients on highly active antiretroviral therapy
J. B. Dinoso et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Microbial translocation is associated with sustained failure in CD4+ T-cell reconstitution in HIV-infected patients on long-term highly active antiretroviral therapy
Giulia Marchetti et al.
AIDS (2008)
CD4+count and risk of non-AIDS diseases following initial treatment for HIV infection
Jason V. Baker et al.
AIDS (2008)
Raltegravir with optimized background therapy for resistant HIV-1 infection
Roy T. Steigbigel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
CD4+ cell count 6 years after commencement of highly active antiretroviral therapy in persons with sustained virologic suppression
Richard D. Moore et al.
CLINICAL INFECTIOUS DISEASES (2007)
Microbial translocation is a cause of systemic immune activation in chronic HIV infection
Jason M. Brenchley et al.
NATURE MEDICINE (2006)
Comparative analysis of T-cell turnover and homeostatic parameters in HIV-infected patients with discordant immune-virological responses to HAART
Giulia Marchetti et al.
AIDS (2006)
Liver-related deaths in persons infected with the human immunodeficiency virus -: The D:A:D study
Rainer Weber
ARCHIVES OF INTERNAL MEDICINE (2006)
Low CD4+ T-cell counts in HIV patients receiving effective antiretroviral therapy are associated with CD4+ T-cell activation and senescence but not with lower effector memory T-cell function
Sonia Fernandez et al.
CLINICAL IMMUNOLOGY (2006)
Thymic function in severely immunodeficient HIV type 1-infected patients receiving stable and effective antiretroviral therapy
S Fernandez et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2006)
Impact of hepatitis C virus on immune restoration in HIV-infected patients who start highly active antiretroviral therapy: A meta-analysis
MF Miller et al.
CLINICAL INFECTIOUS DISEASES (2005)
Mechanisms involved in the low-level regeneration of CD4+ cells in HIV-1-infected patients receiving highly active antiretroviral therapy who have prolonged undetectable plasma viral loads
O Benveniste et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Low-level viremia and proviral DNA impede immune reconstitution in HIV-1-infected patients receiving highly active antiretroviral therapy
SR Ostrowski et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Long-term changes in circulating CD4 T lymphocytes in virologically suppressed patients after 6 years of highly active antiretroviral therapy
K Smith et al.
AIDS (2004)
CD4 T-lymphocyte recovery in individuals with advanced HIV-1 infection receiving potent antiretroviral therapy for 4 years - The Swiss HIV cohort study
GR Kaufmann et al.
ARCHIVES OF INTERNAL MEDICINE (2003)
Productive infection maintains a dynamic steady state of residual viremia in human immunodeficiency virus type 1-infected persons treated with suppressive antiretroviral therapy for five years
DV Havlir et al.
JOURNAL OF VIROLOGY (2003)
Continued CD4 cell count increases in HIV-infected adults experiencing 4 years of viral suppression on antiretroviral therapy
PW Hunt et al.
AIDS (2003)
T cell activation is associated with lower CD4+ T cell gains in human immunodeficiency virus-infected patients with sustained viral suppression during antiretroviral therapy
PW Hunt et al.
JOURNAL OF INFECTIOUS DISEASES (2003)
The potential for CD4 cell increases in HIV-positive individuals who control viraemia with highly active antiretroviral therapy
CJ Smith et al.
AIDS (2003)
Initial responses to endotoxins and Gram-negative bacteria
D Heumann et al.
CLINICA CHIMICA ACTA (2002)
Relationship between the size of the human immunodeficiency virus type 1 (HIV-1) reservoir in peripheral blood CD4+ T cells and CD4+:CD8+ T cell ratios in aviremic HIV-1-Infected individuals receiving long-term highly active antiretroviral therapy
TW Chun et al.
JOURNAL OF INFECTIOUS DISEASES (2002)
The extent of HIV-1-related immunodeficiency and age predict the long-term CD4 T lymphocyte response to potent antiretroviral therapy
GR Kaufmann et al.
AIDS (2002)
Plasma CD14 decreases monocyte responses to LPS by transferring cell-bound LPS to plasma lipoproteins
RL Kitchens et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)
Influence of age on CD4 cell recovery in human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy: Evidence from the EuroSIDA study
JP Viard et al.
JOURNAL OF INFECTIOUS DISEASES (2001)
Active immunization with a detoxified Escherichia coli J5 lipopolysaccharide group B meningococcal outer membrane protein complex vaccine protects animals from experimental sepsis
AS Cross et al.
JOURNAL OF INFECTIOUS DISEASES (2001)
Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study
G Greub et al.
LANCET (2000)
Treatment of enterotoxigenic and enteropathogenic Escherichia coli-induced diarrhoea in children with bovine immunoglobulin milk concentrate from hyperimmunized cows:: A double-blind, placebo-controlled, clinical trial
TH Casswall et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2000)
Thymic size and lymphocyte restoration in patients with human immunodeficiency virus infection after 48 weeks of zidovudine, lamivudine, and ritonavir therapy
KY Smith et al.
JOURNAL OF INFECTIOUS DISEASES (2000)
Share Paper
